Glycopyrrolate Injection, Solution
Product Images NDC 55150-293

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 55150-293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Auromedics Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (0.2 mg per mL)

This text describes a prescription medication labeled as NDC 55150-292-01, which contains benzyl alcohol and lycopyrrolate. It is intended for intramuscular or intravenous use in newborns, but the purpose of the medication is not specified. The manufacturer is AroMedics Pharma LLC, and the medication comes in single-dose vials. The text also includes a date of 2010.*

FDA Label Image

Package Label-principal Display Panel (0.2 mg per mL)

The text appears to be a pharmaceutical label for Glycopyrrolate Injection, USP to be used for intramuscular or intravenous administration. It contains 0.2 mg of Glycopyrrolate and 0.9% Benzyl Alcohol (as a preservative) in each mL of water for injection USP. The vials (25x1mL) should be stored at 20° to 25°C (68° to 77°F). The label warns that the Glycopyrrolate Injection, USP is not for use in newborns and contains Benzyl Alcohol. The label also notes the distributor for the product as AuroMedics Pharma LLC.*

FDA Label Image

Package Label-principal Display Panel (0.4 mg per 2 mL (0.2 mg / mL))

This is a description for a medication containing Glycopyrrolate. It is in the form of an injection and is only available by prescription. The medication comes in a single dose vial of 2mL. The concentration of the active ingredient Glycopyrrolate is 0.4mg per 2mL (0.2mg/ml). The medication contains Benzyl Alcohol. The label warns against use in newborns. The manufacturer is E.Windsor in NJ with the product code TSDRUGS132010.*

FDA Label Image

Package Label-principal Display Panel (0.4 mg per 2 mL (0.2 mg / mL))

This is a pharmaceutical label for an injection containing glycopyrrolate and benzyl alcohol. It is for intravenous or intramuscular use and is distributed by AuroMedics PharmaLLC. The vial stopper is not made with natural rubber latex and the injection is pH adjusted with hydrochloric acid and/or sodium hydroxide. It is stored at controlled room temperatures and contains benzyl alcohol as a preservative. It comes in single-dose vials.*

FDA Label Image

Package Label-principal Display Panel (1 mg per 5 mL (0.2 mg / mL))

This is a description of a medication called Glycopyrrolate Injection, USP with NDC 55150-294-05 that is not for use in newborns. Each mL of the medication contains 0.2 mg of Glycopyrrolate, USP, water, and 0.9% of Benzyl Alcohol which serves as a preservative. It is intended for IM or IV use and is supplied in a 5mL multiple-dose vial. The usual dosage is available in the package insert.*

FDA Label Image

Package Label-principal Display Panel (1 mg per 5 mL (0.2 mg / mL))

This text appears to be a combination of random letters, numbers, and symbols that do not form coherent sentences or paragraphs. Therefore, it is not possible to generate a useful description.*

FDA Label Image

Package Label-principal Display Panel (4 mg per 20 mL (0.2 mg / mL))

This is a medication described as "Rxonly NDC 55150-295-20" that is used for intramuscular or intravenous purposes only. It contains 0.2 mg of Glycopyrrolate, USP per mL, and water for injection, USP gs, and Benzyl Alcohol, NF (preservative) 0.9%. The dosage information is available on the package insert, and it should be stored at 20° to 25°C (68°10 77°F) in a controlled room temperature. This medication is not to be used in newborns as it contains benzyl alcohol. The medication comes in a 20 mL multiple-dose vial and is distributed by AuroMedics Pharma LLC.*

FDA Label Image

Package Label-principal Display Panel (4 mg per 20 mL (0.2 mg / mL))

The text describes a product from AuroMedics, which comes in 25x20 mL vials, for intravenous or intramuscular use. The product contains Glycopyrrolate and Benzyl Alcohol, and is stored at controlled room temperature. The vial stopper is not made with natural rubber latex. The text also includes information on the manufacturer's address, and batch and expiry coding.*

FDA Label Image

Glycopyrrolate Chemical Structure (Glycopyrrolate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.